Editorial Standards

Latest News Today maintains rigorous editorial standards. Our team verifies information from trusted sources and provides context to help readers understand complex stories.

Last Updated: Thursday, October 1, 2026 at 06:08 PM
Category: Id

Editor's Note

Latest News Today provides comprehensive coverage and analysis of breaking news stories. This article is part of our ongoing coverage of wbna55990530, bringing you verified information from trusted sources with added context and expert perspective.

Why This Matters: Understanding the full context of this story helps readers make informed decisions and stay updated on developments that impact our community.

Google to Break Ground on Life-Prolonging Research Facility

Google-backed biotech company Calico has also forged a partnership with a Chicago-based biopharmaceutical firm to develop age-defying drugs.

Roughly one year after tendering a founding investment in biotech company Calico, Google is breaking ground on a brand new Bay Area research facility with a lofty life-prolonging aim.

To this end, Calico has also forged a partnership with a Chicago-based biopharmaceutical company called AbbVie, in order to develop drugs that will tackle aging and age-related diseases such as neurodegeneration and cancer. A forthcoming state-of-the-art research and development center will house this secretive and vastly experimental work.

Each company will contribute between $250 million and $1.5 billion in funding, according to a press release. The affiliation will call for Google-backed Calico’s far-out findings, spearheaded over the next five years, to be eventually tested for commercial viability by AbbVie. “Both parties will share costs and profits equally,” the companies said.

Related: If You Could, Would You Want to Live Forever? Google Thinks You Might

“Last fall, [Google co-founder] Larry Page and I announced Calico, a new company designed to take the long-term view on aging and illness,” wrote Calico chief executive Arthur Levinson in a Google+ post announcing the collaboration yesterday. “Our goal is to make progress on a very basic challenge: how to help people stay healthier for longer.”

Levinson, who also serves as Apple's chairman of the board, created Calico alongside Google’s Page, who notably suffers from a rare nerve condition that affects his ability to speak.

Calico is by no means Google’s only stab into the health-care sector. Despite expressing reservations in regards to entering the heavily regulated space, the company has begun collecting anonymous genetic information from 175 volunteers in order to build a perfect model of human health. The Baseline Study, as the project is called, is part of the company’s “moonshot” division, Google X.

Related: Google Wants to Build a Model of Perfect Human Health